公开(公告)号：US20240350680A1

公开(公告)日：2024-10-24

申请号：US18440783

申请日：2024-02-13

Applicant: NOVARTIS AG

Inventor： Matthias EDER ,  Klaus KOPKA ,  Martin SCHÄFER ,  Ulrike BAUDER-WÜST ,  Michael EISENHUT ,  Walter MIER ,  Martina BENESOVA

IPC: A61K51/04 ,  C07B59/00 ,  C07D257/02 ,  C07D295/145

CPC classification number: A61K51/0482 ,  A61K51/0402 ,  A61K51/0497 ,  C07B59/002 ,  C07D257/02 ,  C07D295/145

Abstract: The present invention generally relates to the field of radiopharmaceuticals and their use in nuclear medicine as tracers, imaging agents and for the treatment of various disease states of prostate cancer. Thus, the present invention concerns compounds that are represented by the general Formulae (Ia) or (Ib).

公开(公告)号：US20240382631A1

公开(公告)日：2024-11-21

申请号：US18628570

申请日：2024-04-05

Applicant: NOVARTIS AG

Inventor： Matthias EDER ,  Klaus KOPKA ,  Martin SCHÄFER ,  Ulrike BAUDER-WÜST ,  Michael EISENHUT ,  Walter MIER ,  Martina BENESOVA

IPC: A61K51/04 ,  C07B59/00 ,  C07D257/02 ,  C07D295/145

Abstract: The present invention generally relates to the field of radiopharmaceuticals and their use in nuclear medicine as tracers, imaging agents and for the treatment of various disease states of prostate cancer. Thus, the present invention concerns compounds that are represented by the general Formulae (Ia) or (Ib).